Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer

Objective: We aimed to explore the relationship between peripheral blood circulating tumor cells (CTCs) and the expression of Claudin-4 in patients with breast cancer, and further explore the potential impact on clinical prognosis and risk assessment.Methods: We classified and enumerated circulating...

Full description

Bibliographic Details
Main Authors: Jie Chai, Xiangli Liu, Xinju Hu, Chunfang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Pathology and Oncology Research
Subjects:
Online Access:https://www.por-journal.com/articles/10.3389/pore.2023.1611224/full
_version_ 1827290250993467392
author Jie Chai
Xiangli Liu
Xinju Hu
Chunfang Wang
author_facet Jie Chai
Xiangli Liu
Xinju Hu
Chunfang Wang
author_sort Jie Chai
collection DOAJ
description Objective: We aimed to explore the relationship between peripheral blood circulating tumor cells (CTCs) and the expression of Claudin-4 in patients with breast cancer, and further explore the potential impact on clinical prognosis and risk assessment.Methods: We classified and enumerated circulating tumor cells in the blood of breast cancer patients by CTC-enriched in situ hybridization and the detection of Claudin-4 expression by immunohistochemistry. We carried out an analysis of the correlation between the two and the comparison of their impact on clinical parameters and prognosis.Results: There were 38 patients with a low expression of Claudin-4 and 27 patients with a high expression of Claudin-4. Compared with Claudin-4 low-expression patients, the number of CTCs was higher in patients with high Claudin-4 expression (11.7 vs. 7.4, p < 0.001). High Claudin-4 expression was associated with a lower count of epithelial CTCs (E-CTCs) (3.4 vs. 5.0, p = 0.033), higher counts of mesenchymal CTCs (M-CTC) (4.4 vs. 1.1, p < 0.001), and epithelial/mesenchymal CTCs (E/M-CTCs) (4.0 vs. 3.5, p = 0.021). The intensity of Claudin-4 was positively correlated with CTC (rs = 0.43, p = 0.001). Multivariate COX regression analysis showed that CTC counts (HR = 1.3, p < 0.001), Claudin-4 (HR = 4.6, p = 0.008), and Lymphatic metastasis (HR = 12.9, p = 0.001) were independent factors for poor prognosis. COX regression of CTC classification showed that epithelial/mesenchymal CTCs (E/M-CTC) (HR = 1.9, p = 0.001) and mesenchymal CTCs (M-CTC) (HR = 1.5, p = 0.001) were independent influencing factors of adverse reactions in breast cancer patients.Conclusion: The number of CTC in breast cancer is positively correlated with the expression of Claudin-4. High CTC counts and a high proportion of M-CTCs correlated with Claudin-4 expression. CTC counts and Claudin-4 expression were independent predictors of poor prognosis in breast cancer patients.
first_indexed 2024-04-24T12:13:21Z
format Article
id doaj.art-387291c059354aa4ad748b5582fcf4ec
institution Directory Open Access Journal
issn 1532-2807
language English
last_indexed 2024-04-24T12:13:21Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Pathology and Oncology Research
spelling doaj.art-387291c059354aa4ad748b5582fcf4ec2024-04-08T09:40:38ZengFrontiers Media S.A.Pathology and Oncology Research1532-28072023-07-012910.3389/pore.2023.16112241611224Correlation analysis of circulating tumor cells and Claudin-4 in breast cancerJie Chai0Xiangli Liu1Xinju Hu2Chunfang Wang3Pathology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, ChinaPathology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, ChinaPathology Department, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, ChinaBreast Surgery, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, ChinaObjective: We aimed to explore the relationship between peripheral blood circulating tumor cells (CTCs) and the expression of Claudin-4 in patients with breast cancer, and further explore the potential impact on clinical prognosis and risk assessment.Methods: We classified and enumerated circulating tumor cells in the blood of breast cancer patients by CTC-enriched in situ hybridization and the detection of Claudin-4 expression by immunohistochemistry. We carried out an analysis of the correlation between the two and the comparison of their impact on clinical parameters and prognosis.Results: There were 38 patients with a low expression of Claudin-4 and 27 patients with a high expression of Claudin-4. Compared with Claudin-4 low-expression patients, the number of CTCs was higher in patients with high Claudin-4 expression (11.7 vs. 7.4, p < 0.001). High Claudin-4 expression was associated with a lower count of epithelial CTCs (E-CTCs) (3.4 vs. 5.0, p = 0.033), higher counts of mesenchymal CTCs (M-CTC) (4.4 vs. 1.1, p < 0.001), and epithelial/mesenchymal CTCs (E/M-CTCs) (4.0 vs. 3.5, p = 0.021). The intensity of Claudin-4 was positively correlated with CTC (rs = 0.43, p = 0.001). Multivariate COX regression analysis showed that CTC counts (HR = 1.3, p < 0.001), Claudin-4 (HR = 4.6, p = 0.008), and Lymphatic metastasis (HR = 12.9, p = 0.001) were independent factors for poor prognosis. COX regression of CTC classification showed that epithelial/mesenchymal CTCs (E/M-CTC) (HR = 1.9, p = 0.001) and mesenchymal CTCs (M-CTC) (HR = 1.5, p = 0.001) were independent influencing factors of adverse reactions in breast cancer patients.Conclusion: The number of CTC in breast cancer is positively correlated with the expression of Claudin-4. High CTC counts and a high proportion of M-CTCs correlated with Claudin-4 expression. CTC counts and Claudin-4 expression were independent predictors of poor prognosis in breast cancer patients.https://www.por-journal.com/articles/10.3389/pore.2023.1611224/fullbreast cancercirculating tumor cellstight junction proteinclaudin-4molecular subtype
spellingShingle Jie Chai
Xiangli Liu
Xinju Hu
Chunfang Wang
Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
Pathology and Oncology Research
breast cancer
circulating tumor cells
tight junction protein
claudin-4
molecular subtype
title Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
title_full Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
title_fullStr Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
title_full_unstemmed Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
title_short Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
title_sort correlation analysis of circulating tumor cells and claudin 4 in breast cancer
topic breast cancer
circulating tumor cells
tight junction protein
claudin-4
molecular subtype
url https://www.por-journal.com/articles/10.3389/pore.2023.1611224/full
work_keys_str_mv AT jiechai correlationanalysisofcirculatingtumorcellsandclaudin4inbreastcancer
AT xiangliliu correlationanalysisofcirculatingtumorcellsandclaudin4inbreastcancer
AT xinjuhu correlationanalysisofcirculatingtumorcellsandclaudin4inbreastcancer
AT chunfangwang correlationanalysisofcirculatingtumorcellsandclaudin4inbreastcancer